In our study, mRNA level of Cdk2, Cdk4 and Cdk6 down-regulated in MPT0B291-treated glioma cells indicating that HDAC6 inhibitor transcriptionally regulates those cyclin-dependent kinases. This evidence concerns the gene CDK2 and central nervous system cancer.